Cardiac rhythm management (CRM) is used in cases of higher, lower, and irregular heartbeat. CRM involves synchronizing the heart rhythm for increasing the efficiency of heart. It needs modifying heart's electrical conduction system for modulating heart rate and altering irregular rhythm. CRM helps in treating disorders such as tachycardia, bradycardia, arrhythmias such as atrial fibrillation, Ventricular fibrillation, sinus arrhythmia, etc. CRM is achieved using pacemakers, defibrillators and cardiac resynchronization therapy devices.
Cardiac rhythm management market is estimated to grow steadily in the forecast period (2015 to 2020).
Increasing incidence of lifestyle diseases & cardiovascular diseases, technological advances in cardiac domain & remote monitoring facility, government regulations in favor of cardiac monitoring in many countries, growing need for cardiac rhythm management and secondary factors such as rapidly increasing smoking and alcohol consumption rate, etc. are some of the key factors driving the growth of Cardiac rhythm management market. However, a number of factors, such as Economic Downturn & Saturation of pacing implants such as pacemakers, High cost of Cardiac Rhythm Management devices, frequent product recalls and possible competition from Nanostim are restricting the growth of this market.
CRM technology evolution has many upgrades in the recent past. These devices evolved in terms of size, reliability, sensitivity, automation, and performance. Some of the recent advancement in cardiac monitoring engineering has resulted in tracking patient status remotely; improvise ECG data management systems and MRI compatibility.
Remote monitoring facility helps patients to send their cardiac statistics on a regular basis to a healthcare professional. It automatically highlights any non-physiological data patterns and alert in case of any emergency. Remote monitoring helps to identify and devise patient specific treatment plan to optimize the therapy management. ECG data management systems look for irregular, premature or rapid heartbeats, fainting episodes or patients who may be at risk of sudden cardiac arrest. ECG data management systems identify the need of a pacemaker or automatic defibrillator or any potential genetic links to heart rhythm problems.
With the launch of technological advancements such as MRI pacemakers, subcutaneous ICDs, home automated external defibrillators (AEDs), this segment is expected to grow steadily. Fool proof systems are developed to improvise the performance by using algorithms for protection against inappropriate and unnecessary shocks, higher number of pacing configurations and providing longer battery life.
This research report analyzes this market on the basis of its various market segments, major geographies, and current market trends.
Geographies analyzed under this research report include:
This report is a comprehensive study of current trends in the market, industry growth drivers, and restraints. It provides market numbers for the period 2012 to the year 2020. the year 2014 is considered as a base year. This report includes analysis of recent developments in technology, detailed profiles of top industry players, micro and macro factors involved in this industry.